Cargando…
An Overview on the Clinical Development of Tau-Based Therapeutics
Tauopathies such as Alzheimer’s disease (AD), frontotemporal lobar degeneration, or progressive supranuclear palsy constitute a group of brain disorders defined by neurodegeneration and the presence of tau aggregates in the affected brains regions. Tau is a microtubule-associated protein that accumu...
Autor principal: | Medina, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979300/ https://www.ncbi.nlm.nih.gov/pubmed/29641484 http://dx.doi.org/10.3390/ijms19041160 |
Ejemplares similares
-
Recent developments in tau-based therapeutics for Alzheimer’s disease and related dementsia
por: Medina, Miguel
Publicado: (2015) -
An overview of development in gene therapeutics in China
por: Wang, Dawei, et al.
Publicado: (2020) -
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies
por: Medina, Miguel, et al.
Publicado: (2011) -
Overview of the tau-charm factory
por: Kirkby, Jasper
Publicado: (1996) -
New Features about Tau Function and Dysfunction
por: Medina, Miguel, et al.
Publicado: (2016)